Quantcast

Industry news that matters to you.  Learn more

KalGene Pharmaceuticals, Sunnybrook Research Institute, Ontario Cancer Biomarker Network and CIMTEC Announce Multi-year Collaboration to Tackle Aggressive Cancers

KalGene Pharmaceuticals, Inc. (KalGene) is expediting development of a prognostic marker and companion therapeutic that specifically targets aggressive cancers. 

Lundbeck Canada Donates $2.7 Million to Fund Ground-breaking Depression Research

Lundbeck Canada has made a landmark donation of $2.7 million to support ground-breaking research at the University Health Network to identify biomarkers (biological markers) that will enhance the diagnosis and treatment of patients suffering from major depression and bipolar disorder.

Thirteen Proteomics Companies Form Proteomics Innovation Network

New England Peptide recently announced that it and twelve other product and service companies have started the global Proteomics Innovation Network to collaborate on unmet needs in drug discovery and personalized medicine.

The mission of the new proteomics network is to generate “from sample to discovery” solutions in all facets of proteomics, including expression, identification, characterization, interaction and function. Each member organization has complementary expertise, core technologies, and infrastructure to address critical unmet needs in biomarker and drug target discovery, personalized medicine, drug profiling, and selective reaction monitoring.